GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a remarkable innovation in how we treat type 2 diabetes . These new drugs work by imitating the body’s natural GLP-1 process, https://digibookmarks.com/story21640983/glp-1-a-major-approach-in-diabetes-treatment